Haematological malignancies cancer susceptibilityGene: FANCM
Comment on list classification: Currently lack of evidence for fanconi anaemia.
Created: 26 Jul 2018, 8:11 a.m.
Publication PMID: 28837162 entitled: “Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility.” In this study breast cancer probands were investigated for DNA damage response genes, and 5 cases had FANCM loss-of-function variants. They showed a heterogeneous phenotype including cancer predisposition, toxicity to chemotherapy, early menopause, and possibly chromosome fragility. The phenotype severity might correlate with mutation position in the gene. They authors conclude: “Our data indicate that biallelic FANCM mutations do not cause classical FA, providing proof that FANCM is not a canonical FA gene. Moreover, our observations support previous findings suggesting that FANCM is a breast cancer-predisposing gene. Mutation testing of FANCM might be considered for individuals with the above-described clinical features.”
Created: 2 Nov 2017, 2:23 p.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Ellen McDonagh: Publication PMID: 28837162 ent
Gene: fancm has been classified as Amber List (Moderate Evidence).
Gene: fancm has been classified as Red List (Low Evidence).
Expert Review Green was added to FANCM. Panel: Haematological malignancies pertinent cancer susceptibility
FANCM was created by ellenmcdonagh
FANCM was added to Haematological malignanciespanel. Sources: Curated sources